Can Ramipril (Angiotensin-Converting Enzyme Inhibitor) be taken twice a day (bid)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ramipril Administration: Once vs. Twice Daily Dosing

Yes, ramipril can be taken twice daily (bid) in specific clinical scenarios, though once-daily dosing is the standard regimen for most patients with hypertension.

FDA-Approved Dosing Regimens

  • For hypertension, ramipril can be administered as "a single dose or in two equally divided doses" with a maintenance dosage range of 2.5-20 mg per day 1
  • In patients treated once daily where the antihypertensive effect diminishes toward the end of the dosing interval, twice daily administration should be considered 1
  • For heart failure post-myocardial infarction, ramipril is specifically recommended as twice daily dosing, starting at 2.5 mg twice daily (5 mg total daily dose) with a target dose of 5 mg twice daily 1

Clinical Evidence Supporting Different Dosing Schedules

  • The 2020 ACC/AHA guidelines specifically list ramipril's target dose for heart failure with reduced ejection fraction (HFrEF) as 10 mg once daily 2
  • In clinical trials for heart failure, ramipril has been used at a twice daily dose of 5 mg, while in the HOPE study (for cardiovascular prevention), it was used as 10 mg once at bedtime 3
  • A randomized crossover trial comparing once-daily (10 mg) versus twice-daily (5 mg bid) dosing found that both regimens effectively lowered blood pressure to a similar extent over a 24-hour period 3

Factors Affecting Dosing Decision

  • Patient-specific factors that may favor twice-daily dosing include:

    • Heart failure post-myocardial infarction (specifically indicated for bid dosing) 1
    • Patients whose blood pressure control diminishes toward the end of a once-daily dosing interval 1
    • Patients with renal impairment who require dose adjustment 1
  • Pharmacokinetic considerations:

    • Ramipril is a long-acting ACE inhibitor that can generally maintain therapeutic effect over 24 hours with once-daily dosing 4, 5
    • Renal excretion largely determines the drug's duration of action, which may affect dosing frequency in patients with impaired kidney function 5

Clinical Recommendations

  • For most hypertensive patients, once-daily dosing of ramipril is sufficient and preferred for adherence 4
  • For post-MI heart failure patients, follow the specific twice-daily dosing regimen starting at 2.5 mg bid with target of 5 mg bid 1
  • Monitor blood pressure response throughout the dosing interval; if control wanes before the next dose, consider switching to twice-daily administration 1
  • When using twice-daily dosing, divide the total daily dose equally (e.g., 10 mg daily would become 5 mg twice daily) 1, 3

Important Considerations

  • Always titrate ramipril to the maximally tolerated dose to achieve optimal clinical outcomes 2
  • For heart failure patients, therapies must be initiated and titrated to maximally tolerated doses to improve mortality and morbidity outcomes 2
  • The target dose of ramipril for heart failure is 10 mg daily, with 5 mg daily considered 50% of target dose 2
  • When switching between once and twice daily dosing, maintain the same total daily dose unless clinical factors indicate otherwise 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.